Article

Recent successes of tissue bioengineering in ophthalmology highlighted

Rutledge Ellis-Behnke, PhD, a research scientist in the department of brain and cognitive sciences, Massachusetts Institute of Technology (MIT), Boston, describes his work as reconnecting disconnected parts of the brain. He has done just that by using nanotechnology restore visual function in a damaged area of the brain in rodents.

Rutledge Ellis-Behnke, PhD, a research scientist in the department of brain and cognitive sciences, Massachusetts Institute of Technology (MIT), Boston, describes his work as reconnecting disconnected parts of the brain. He has done just that by using nanotechnology restore visual function in a damaged area of the brain in rodents.

Dr. Ellis-Behnke and his team at MIT conducted in vivo experiments in young and adult hamsters. After making a deep cut in the superior colliculus, the researchers injected a clear substance containing a self-assembling material made of peptides. This serves as a matrix for new cell growth. The researchers observed new axon growth first in young animals, then carried out a similar experiment in adults in a way that removed all visually-guided orienting behavior, Dr. Ellis-Behnke said.

Six weeks after the cut was made, the researchers began testing the animals and found complete regeneration and functional vision in all but two of the treated animals. In those two, the lack of improvement apparently was due to surgical error, Dr. Ellis-Behnke said. While the animals displayed some signs of healing, it was insufficient to drive their behavior.

In separate experiments, Dr. Ellis-Behnke and colleagues showed that axon growth could be seen in live animals.

Ultimately, they hope to apply these findings on self-assembling peptides and axon growth to humans, Dr. Ellis-Behnke concluded.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game? (Part 1)
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
© 2025 MJH Life Sciences

All rights reserved.